Quality of life and mental health among gynaecological cancer patients towards the end of COVID-19 pandemic

This study aimed to assess the mental health and quality of life (QOL) in gynaecological cancer patients, and to identify key risk factors for improved management. In addition, during a period of reduced impact of a novel coronavirus (COVID-19) infection, we sought to examine its current impact on mental health and QOL. A cross-sectional study was conducted among 175 gynaecological cancer patients. The survey assessed QOL (The World Health Organization Quality of Life-Bref, anxiety and depression (Hospital Anxiety and Depression Scale (HADS)). Multivariable linear regression was used for analysis. Being diagnosed in the last one year was associated with higher HADS depression score (p < 0.001) and recurrence was associated with both higher HADS anxiety and depression scores (p = 0.004 and p < 0.001). Age ≤60 years old was a significant negative predictor for psychological health (p = 0.002) and overall QOL (p = 0.017). Complications during surgery were identified as a significant negative predictor affecting psychological health (p = 0.018), but did not affect the other domains. Disease recurrence was observed to significantly influence QOL scores in physical health (p = 0.014) and overall QOL (p < 0.001). This study highlights that recurrence has a significant impact on mental health and QOL of gynaecological cancer patients. Patients diagnosed within last year should be carefully assessed for risk of depression. Younger patients and those with surgical complications may experience reduced QOL. Importantly, COVID-19 showed no apparent negative impact on the mental health or QOL in these patients, which is no longer considered a significant contributor to adverse effects.

Gynaecological cancer; Quality of life; Anxiety; Depression; COVID-19

[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021; 71: 209–249.

[2] Gil-Ibanez B, Davies-Oliveira J, Lopez G, Díaz-Feijoo B, Tejerizo-Garcia A, Sehouli J. Impact of gynecological cancers on health-related quality of life: historical context, measurement instruments, and current knowledge. International Journal of Gynecologic Cancer. 2023; 33: 1800–1806.

[3] Licu M, Ionescu CG, Paun S. Quality of life in cancer patients: the modern psycho-oncologic approach for Romania—a review. Current Oncology. 2023; 30: 6964–6975.

[4] Mohamad Muhit AM, Sy-Cherng Woon L, Nik Mhd Nor NS, Mohd Kalok AH, Kampan NC, et al. Sexual dysfunction among gynaecological cancer survivors: a descriptive cross-sectional study in Malaysia. International Journal of Environmental Research and Public Health. 2022; 19: 15545.

[5] Cai T, Verze P, Bjerklund Johansen TE. The quality of life definition: where are we going? Uro. 2021; 1: 14–22.

[6] Ghamari D, Dehghanbanadaki H, Khateri S, Nouri E, Baiezeedi S, Azami M, et al. The prevalence of depression and anxiety in women with ovarian cancer: an updated systematic review and meta-analysis of cross-sectional studies. Asian Pacific Journal of Cancer Prevention. 2023; 24: 3315–3325.

[7] Gultekin M, Ak S, Ayhan A, Strojna A, Pletnev A, Fagotti A, et al. Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: a Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe). Cancer Medicine. 2021; 10: 208–219.

[8] Skevington SM, Lotfy M, O’Connell KA; WHOQOL Group. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL Group. Quality of Life Research. 2004; 13: 299–310.

[9] The Whoqol G. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine. 1998; 28: 551–558.

[10] Eser S, Saatli G, Eser E, Baydur H, Fidaner C. The reliability and validity of the Turkish Version of the World Health Organization quality of life instrument-older adults module (WHOQOL-Old). Turkish Journal of Psychiatry. 2010; 21: 37–48.

[11] Stafford L, Judd F, Gibson P, Komiti A, Quinn M, Mann GB. Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer. General Hospital Psychiatry. 2014; 36: 74–80.

[12] Pinar G, Okdem S, Buyukgonenc L, Ayhan A. The relationship between social support and the level of anxiety, depression, and quality of life of Turkish women with gynecologic cancer. Cancer Nursing. 2012; 35: 229–235.

[13] Cooper K, Campbell F, Harnan S, Sutton A. Association between stress, depression or anxiety and cancer: rapid review of reviews. Comprehensive Psychoneuroendocrinology. 2023; 16: 100215.

[14] Nikolopoulos M, Maheshwari MK, Doumouchtsis SK. Impact of COVID-19 in gynaecological oncology care: a systematic rapid review. Archives of Gynecology and Obstetrics. 2022; 305: 555–565.

[15] Klügel S, Lücke C, Meta A, Schild-Suhren M, Malik E, Philipsen A, et al. Concomitant psychiatric symptoms and impaired quality of life in women with cervical cancer: a critical review. International Journal of Women's Health. 2017; 9: 795–805.

[16] Colombo N, Lorusso D, Scollo P. Impact of recurrence of ovarian cancer on quality of life and outlook for the future. International Journal of Gynecologic Cancer. 2017; 27: 1134–1140.

[17] Dahl L, Wittrup I, Væggemose U, Petersen LK, Blaakaer J. Life after gynecologic cancer—a review of patients quality of life, needs, and preferences in regard to follow-up. International Journal of Gynecological Cancer. 2013; 23: 227–234.

[18] Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatric Disease and Treatment. 2019; 15: 857–865.

[19] Wang Y, Lin Y, Chen J, Wang C, Hu R, Wu Y. Effects of internet-based psycho-educational interventions on mental health and quality of life among cancer patients: a systematic review and meta-analysis. Supportive Care in Cancer. 2020; 28: 2541–2552.

[20] Zach D, Jensen PT, Falconer H, Kolkova Z, Bohlin KS, Kjølhede P, et al. Anxiety and depression among women with newly diagnosed vulvar cancer—a nationwide longitudinal study. Acta Obstetricia et Gynecologica Scandinavica. 2024; 103: 396–406.